Fidelity International reduced its stake in HYGEIA HEALTH (06078) by 1.1348 million shares at a price of approximately HK$16.83 per share.
On February 27, Fidelity International reduced its holdings in Haige Medical (06078) by 1.1348 million shares, with a price of 16.8258 Hong Kong dollars per share, for a total amount of approximately 19.0939 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, Fidelity International reduced its holdings of HYGEIA HEALTH (06078) by 1.1348 million shares on February 27th, with each share priced at 16.8258 Hong Kong dollars, for a total amount of approximately 19.0939 million Hong Kong dollars. After the reduction, the new holding number is 36.7496 million shares, with a new holding percentage of 5.91%.
This transaction involves other related parties: Pandanus Associates Inc. and Pandanus Partners L.P.
Related Articles
HK Stock Market Move | Innovative drug concept stocks rebound across the board, with 38 new innovative drugs approved for listing in the first half of the year, with domestic products accounting for over 80%.
HK Stock Market Move | ESSEX BIO-TECH (01061) falls nearly 13% after issuing profit warning, expected mid-term profit to decrease by about 30% year-on-year.
HK Stock Market Move | CLOVER BIO-B(02197) rose by over 5%, expected to turn losses into profits in the first half of the year, earning up to 12.04 billion yuan.
HK Stock Market Move | Innovative drug concept stocks rebound across the board, with 38 new innovative drugs approved for listing in the first half of the year, with domestic products accounting for over 80%.
HK Stock Market Move | ESSEX BIO-TECH (01061) falls nearly 13% after issuing profit warning, expected mid-term profit to decrease by about 30% year-on-year.
HK Stock Market Move | CLOVER BIO-B(02197) rose by over 5%, expected to turn losses into profits in the first half of the year, earning up to 12.04 billion yuan.
RECOMMEND
